期刊文献+

华蟾素对胃癌肿瘤细胞SGC-7901增殖、凋亡以及JAK/STAT3信号通路的影响 被引量:7

Effect of cinobufacin on the proliferation and apoptosis of human gastric carcinoma cell SGC-7901 and JAK/STAT3 signaling pathway
下载PDF
导出
摘要 目的探讨华蟾素(Cino)对转录激活因子3(STAT3)的调控作用,以及对人胃癌肿瘤细胞SGC-7901的增殖、凋亡的影响。方法采用MTT法检测不同浓度华蟾素(0.1、1.0、10 mg/L)及5-FU(20 mg/L)分别作用于人胃癌肿瘤SGC-7901细胞12、24、48 h后对肿瘤细胞增殖活力的影响;半定量RT-PCR检测Cyclin D1、PCNA、Bcl-2的mRNA表达水平;蛋白悬液芯片(Bio-plex)法检测STAT3磷酸化(p-STAT3)蛋白表达水平。结果华蟾素可显著抑制SGC-7901的增殖,且呈时间和剂量依赖性。华蟾素能抑制SGC-7901细胞Cyclin D1、PCNA、Bcl-2的mRNA表达水平(均P<0.05)。华蟾素抑制p-STAT3蛋白表达水平,且呈现剂量依赖性(P<0.05)。结论华蟾素具有抑制胃癌肿瘤细胞增殖和诱导凋亡的作用,其可能机制与其抑制STAT3活化,从而抑制其下游靶基因表达有关。 Objective To explore the regulating effect of cinobufacin on signal transducer and activator of transcription 3(STAT3) and the effect on the proliferation and apoptosis in human gastric carcinoma cell SGC-7901. Methods SGC-7901 cells were incubated with the cinobufacin at different concentrations(0.1, 1.0, 10 mg/L) and 5-FU(20 mg/L) for 12, 24, and48 h, respectively. MTT method was used to measure the effect on the proliferation activity of SGC-7901 cells. Semiquantitative RT-PCR was used to determine the mRNA expression of Cyclin D1, PCNA and Bcl-2 in SGC-7901 cells. The protein expression of phosphorylated STAT3(p-STAT3) in SGC-7901 cells was detected by Bio-plex. Results Cinobufacin inhibited the proliferation of SGC-7901 cells in a dose-and time-dependent manner. Cinobufacin inhibited the mRNA expression level of Cyclin D1, PCNA and Bcl-2 of SGC-7901 cells(P〈0.05). Moreover, cinobufacin decreased the protein expression of p-STAT3(P〈0.05) in a dose dependent manner. Conclusion Cinobufacin can inhibit the proliferation and induce apoptosis in gastric cancer cells. The possible mechanism may be related to that it inhibits activation of STAT3 and thus inhibit the expression of downstream target gene.
作者 陈元岩 钟俊新 吴雪松 陈嘉勇 CHEN Yuan-yan;ZHONG Jun-xin;WU Xue-song;CHEN Jia-yong(Department of Gastrointestinal Surgery,Guangzhou Hospital of Integrated Traditional and West Medicine,Guangzhou,510800,China;Department of Gastrointestinal Surgery,Second Affiliated Hospital of Kunming Medical University,Yunnan,65010,China)
出处 《广东医科大学学报》 2018年第2期152-155,共4页 Journal of Guangdong Medical University
基金 广东省中医药局科研资助项目(No.20171221)
关键词 华蟾素 肿瘤细胞 细胞增殖 凋亡 JAK/STAT3信号通路 cinobufacin tumor cell cell proliferation apoptosis JAK/STAT3 signaling pathway
  • 相关文献

参考文献3

二级参考文献85

  • 1岳利华,程金妹,张鹏飞,林功标,易自翔,张榕.STAT3和STAT5与Survivin和Ki67蛋白在鼻NK/T细胞淋巴瘤中的表达及意义[J].临床耳鼻咽喉头颈外科杂志,2006,20(20):931-933. 被引量:5
  • 2郭昱,姚树坤.黄芩甙对人肝癌BEL-7402细胞系侵袭和转移的影响[J].第三军医大学学报,2006,28(6):594-597. 被引量:16
  • 3Kang YK;Kang WK;Shin DB.Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer:a randomised phase Ⅲ noninferiority trial[J]Annals of Oncology,2009(04):666-673.
  • 4Cunningham D;Starling N;Rao S.Capecitabine and oxaliplatin for advanced esophagogastric cancer[J]the New England Journal of Medicine,2008(01):36-46.
  • 5Koizumi W,Takiuchi H,Yamada Y. Phase Ⅱ study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)[J].Annals of Oncology,2010,(05):1001-1005.
  • 6Boku N,Yamamoto S,Fukuda H. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer:a randomised phase 3 study[J].Lancet Oncology,2009,(11):1063-1069.doi:10.1016/S1470-2045(09)70259-1.
  • 7Wagner AD,Unverzagt S,Grothe W. Chemotherapy for advanced gastric cancer[J].Cochrane Database of Systematic Reviews,2010,(03):CD004064.
  • 8Pyrhonen S,Kuitunen T,Nyandoto P. Randomised comparison of fluorouracil,epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer[J].British Journal of Cancer,1995,(03):587-591.doi:10.1038/bjc.1995.114.
  • 9Koizumi W,Narahara H,Hara T. S-1 plus cisplatin versus S-l alone for fi rst-line treatment of advanced gastric cancer (SPIRITS trial):a phase Ⅲ trial[J].Lancet Oncology,2008,(03):215-221.doi:10.1016/S1470-2045(08)70035-4.
  • 10Ohtsu A,Shimada Y,Shirao K. Randomized phase Ⅲ trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable,advanced gastric cancer:The Japan Clinical Oncology Group Study (JCOG9205)[J].Journal of Clinical Oncology,2003,(01):54-59.doi:10.1200/JCO.2003.04.130.

共引文献29

同被引文献94

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部